Online first
Original Article
Published online: 2024-06-04

open access

Page views 225
Article views/downloads 132
Get Citation

Connect on Social Media

Connect on Social Media

Phenotype clustering of hospitalized high-risk patients with COVID-19 — a machine learning approach within the multicentre, multinational PCHF-COVICAV registry

Pubmed: 38832553

Abstract

Imtroduction: The high-risk population of patients with cardiovascular (CV) disease or risk factors (RF) suffering from COVID-19 is heterogeneous. Several predictors for impaired prognosis have been identified. However, with machine learning (ML) approaches, certain phenotypes may be confined to classify the affected population and to predict outcome. This study aimed to phenotype patients using unsupervised ML technique within the International Postgraduate Course Heart Failure Registry for patients hospitalized with COVID-19 and Cardiovascular disease and/or RF (PCHF-COVICAV).

Material and methods: Patients from the eight centres with follow-up data available from the PCHF-COVICAV registry were included in this ML analysis (K-medoids algorithm).

Results: Out of 617 patients included into the prospective part of the registry, 458 [median age: 76 (IQR:65–84) years, 55% male] were analyzed and 46 baseline variables, including demographics, clinical status, comorbidities and biochemical characteristics were incorporated into the ML. Three clusters were extracted by this ML method. Cluster 1 (n = 181) represents mainly women with the least number of overall comorbidities and cardiovascular RF. Cluster 2 (n = 227) is characterized mainly by men with non-CV conditions and less severe symptoms of infection. Cluster 3 (n=50) mainly represents men with the highest prevalence of cardiac comorbidities and RF, more extensive inflammation and organ dysfunction with the highest 6-month all-cause mortality risk.

Conclusions: The ML process has identified three important clinical clusters from hospitalized COVID-19 CV and/or RF patients. The cluster of males with severe CV disease, particularly HF, and multiple RF presenting with increased inflammation had a particularly poor outcome.

Article available in PDF format

View PDF Download PDF file

References

  1. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int (09.07.2023.).
  2. Pepera G, Tribali MS, Batalik L, et al. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review. Rev Cardiovasc Med. 2022; 23(1): 28.
  3. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239–1242.
  4. Gao YD, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021; 76(2): 428–455.
  5. Ritchie H, Mathieu E, Rodés-Guirao L, et al. Coronavirus Pandemic (COVID-19). Our World Data. 2020. Available at: https://ourworldindata.org/covid-vaccinations. Assessed 09. ; 07: 2023.
  6. AlShahrani I, Hosmani J, Shankar VG, et al. COVID-19 and cardiovascular system-a comprehensive review. Rev Cardiovasc Med. 2021; 22(2): 343–351.
  7. Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020; 146(1): 110–118.
  8. Gao C, Cai Y, Zhang K, et al. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J. 2020; 41(22): 2058–2066.
  9. Sokolski M, Trenson S, Sokolska JM, et al. Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry. ESC Heart Fail. 2021; 8(6): 4955–4967.
  10. Sokolski M, Reszka K, Suchocki T, et al. History of Heart Failure in Patients Hospitalized Due to COVID-19: Relevant Factor of In-Hospital Complications and All-Cause Mortality up to Six Months. J Clin Med. 2022; 11(1).
  11. Magri MMC, Uip DE, Rodrigues FK, et al. Impact of the Vaccination Against COVID-19 on Frontline Health Workers. Curr Drug Saf. 2023; 18(4): 511–515.
  12. United Nations. https://news.un.org/en/story/2023/05/1136367 ( 09.07.2023).
  13. Malik JA, Ahmed S, Mir A, et al. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges. J Infect Public Health. 2022; 15(2): 228–240.
  14. Aldhoayan MD. The Role of Artificial Intelligence and Machine Learning During the Covid-19 Pandemic: A Review. Stud Health Technol Inform. 2022; 295: 28–32.
  15. Urban S, Błaziak M, Jura M, et al. Novel Phenotyping for Acute Heart Failure-Unsupervised Machine Learning-Based Approach. Biomedicines. 2022; 10(7).
  16. Tan, Pang-Ning, Michael Steinbach, Vipin Kumar. Introduction to data mining. Pearson Education India. 2016.
  17. Kaufman L, Rousseeuw PJ. Partitioning Around Medoids (Program PAM). Finding Groups in Data. 2008: 68–125.
  18. Davies D, Bouldin D. A Cluster Separation Measure. IEEE Transactions on Pattern Analysis and Machine Intelligence. 1979; PAMI-1(2): 224–227.
  19. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234): 1417–1418.
  20. Krittanawong C, Virk HU, Bangalore S, et al. Machine learning prediction in cardiovascular diseases: a meta-analysis. Sci Rep. 2020; 10(1): 16057.
  21. Lu W, Fu D, Kong X, et al. FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms. Cancer Med. 2020; 9(4): 1419–1429.
  22. Castaldo R, Cavaliere C, Soricelli A, et al. Radiomic and Genomic Machine Learning Method Performance for Prostate Cancer Diagnosis: Systematic Literature Review. J Med Internet Res. 2021; 23(4): e22394.
  23. Fleuren LM, Klausch TLT, Zwager CL, et al. Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy. Intensive Care Med. 2020; 46(3): 383–400.
  24. Lee Y, Ragguett RM, Mansur RB, et al. Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review. J Affect Disord. 2018; 241: 519–532.
  25. Xiong Y, Ma Y, Ruan L, et al. National Traditional Chinese Medicine Medical Team. Comparing different machine learning techniques for predicting COVID-19 severity. Infect Dis Poverty. 2022; 11(1): 19.
  26. Li WT, Ma J, Shende N, et al. Using machine learning of clinical data to diagnose COVID-19: a systematic review and meta-analysis. BMC Med Inform Decis Mak. 2020; 20(1): 247.
  27. Ye W, Lu W, Tang Y, et al. Identification of COVID-19 Clinical Phenotypes by Principal Component Analysis-Based Cluster Analysis. Front Med (Lausanne). 2020; 7: 570614.
  28. Lau KYY, Ng KS, Kwok KW, et al. An Unsupervised Machine Learning Clustering and Prediction of Differential Clinical Phenotypes of COVID-19 Patients Based on Blood Tests-A Hong Kong Population Study. Front Med (Lausanne). 2021; 8: 764934.
  29. Ilbeigipour S, Albadvi A, Akhondzadeh Noughabi E. Cluster-based analysis of COVID-19 cases using self-organizing map neural network and K-means methods to improve medical decision-making. Inform Med Unlocked. 2022; 32: 101005.
  30. Nägele MP, Haubner B, Tanner FC, et al. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. 2020; 314: 58–62.
  31. Cui W, Robins D, Finkelstein J. Unsupervised Machine Learning for the Discovery of Latent Clusters in COVID-19 Patients Using Electronic Health Records. Stud Health Technol Inform. 2020; 272: 1–4.
  32. Yan Li, Zhang HT, Goncalves J, et al. An interpretable mortality prediction model for COVID-19 patients. Nature Machine Intelligence. 2020; 2(5): 283–288.
  33. Di Castelnuovo A, Bonaccio M, Costanzo S, et al. COvid-19 RISk and Treatments (CORIST) collaboration. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020; 30(11): 1899–1913.